Most recently, Mr. Augusti served as CEO of Bioventus and was a member of the company’s board of directors. He has more than 25 years of experience in medical technology management and strategic decision-making.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
